Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

CORZ vs PATH: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

PATH Wins Head-to-Head Institutional Verdict (3–3 across 6 Pillars · 7–3 Matrix Metrics)

PATH Overall Winner 6-Pillar Tally: CORZ 3 – 3 PATH Matrix Metrics: CORZ 3 – 7 PATH

As of Nov 16, 2026, UiPath, Inc. (PATH) is the stronger overall head-to-head candidate over Core Scientific, Inc. (CORZ) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Profitability & Quality, Balance Sheet & Cash Flow, R&D & Supply-Chain Moat). CORZ carries a Unified Composite Score of 40.2/100 (SELL) at $13.47 (16.6x Forward P/E, -2.1% operating margin), whereas PATH carries 58.3/100 (HOLD) at $13.24 (17.4x Forward P/E, 9.4% operating margin).

  • Growth vs. Quality Trade-Off: PATH earns the overall head-to-head edge with a stronger Unified Composite Score (58.3/100 HOLD vs. CORZ 40.2/100 SELL) and 0.86β · 30% Vol risk profile, whereas CORZ leads top-line expansion (+187.1% YoY revenue growth, N/M PEG, and 3 of 6 institutional pillars) for higher-beta growth mandates.
  • Technical & Structure Timing Caution: CORZ is currently in a Breakdown options structure phase (RSI 46.9); meanwhile PATH is in a Weinstein Distribution regime near a flattening 50-day moving average and Breakdown options structure phase (RSI 47.4). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About CORZ vs PATH
CORZ NASDAQ
Core Scientific, Inc. Common Stock
Finance Services
$13.47
-7.2% 1D
Market Cap $4.6B
TTM Revenue $592M
Forward P/E 16.6x
Beta / 30D Vol 2.91β · 109% Vol
Unified Composite Score
40.2 / 100 SELL
Tech 15.0 Fund 44.0 Flow 59.0 Mom 64.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 47
RSI-14: 46.9 · SMA20: $13.51 · SMA50: $15.31
PATH NYSE Head-to-Head Winner
UiPath, Inc.
Services-Prepackaged Software
$13.24
-0.19% 1D
Market Cap $6.8B
TTM Revenue $1.72B
Forward P/E 17.4x
Beta / 30D Vol 0.86β · 30% Vol
Unified Composite Score
58.3 / 100 HOLD
Tech 74.0 Fund 68.0 Flow 68.0 Mom 60.0
Weinstein Technical Phase Distribution · Trim / tighten stop
Price near a flattening SMA50 (slope -8.7%) with fading momentum, RSI 47
RSI-14: 47.4 · SMA20: $13.49 · SMA50: $13.38

6-Pillar Scorecard Institutional Category Breakdown (CORZ 3 – 3 PATH)

Columns: Metric · CORZ · PATH
1. Valuation Multiples CORZ
Forward P/E 16.6x 17.4x
Trailing P/E 16.6x 19.6x
PEG Ratio N/M 0.41x
EV / Revenue 13.7x 3.7x
2. Growth & Scale CORZ
Revenue Growth (YoY) +187.1% +13.4%
Earnings Growth (YoY) +61.2% N/A
TTM Revenue (USD) $592M $1.72B
Market Cap $4.6B $6.8B
3. Profitability & Quality PATH
Gross Margin 44.1% 82.6%
Operating Margin -2.1% 9.4%
Net Profit Margin -18.3% 21.0%
Return on Equity (ROE) 0.0% 20.0%
4. Balance Sheet & Cash Flow PATH
Cash Generation (TTM) -$1.32B $363M
Cash Flow Margin N/A 21.1%
Net Cash / Leverage $3.50B Net Debt $528M Net Cash
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning CORZ
Options Structure Phase BREAKDOWN BREAKDOWN
Current IV / %ile 80.6% (28th %ile) 50.3% (11th %ile)
Put/Call OI Skew 0.36x (Call-Skewed) 0.49x (Call-Skewed)
OBV Trend / Tech Phase ACCUMULATION · Neutral DISTRIBUTION · Distribution
6. R&D & Supply-Chain Moat PATH
OpEx & R&D Intensity 46.2% of Rev ($274M) 73.2% of Rev ($1.26B)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Scale & Operating Efficiency Moat
Supply-Chain Role Software - Infrastructure Operator Software - Infrastructure Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: CORZ (3) vs PATH (7)
Institutional Metric CORZ PATH Criterion Row Edge
Market Capitalization
Scale
$4.6B $6.8B Larger Scale PATH
Trailing P/E Ratio
Valuation
16.6x 19.6x Lower Multiple CORZ
Forward P/E Ratio
Valuation
16.6x 17.4x Lower Multiple CORZ
Revenue Growth (YoY)
Growth
+187.1% +13.4% Higher Growth CORZ
Operating Margin (TTM)
Profitability
-2.1% 9.4% Higher Margin PATH
Net Profit Margin
Profitability
-18.3% 21.0% Higher Margin PATH
Return on Equity (ROE)
Capital Efficiency
0.0% 20.0% Higher ROE PATH
52-Week Range Position
Momentum
14% ($11–$30) 38% ($9–$20) Stronger Trend PATH
Beta / 30D Volatility
Risk Regime
2.91β · 109% Vol 0.86β · 30% Vol Lower Realized Risk PATH
Unified Institutional Score
Composite Signal
40.2 / 100 (SELL) 58.3 / 100 (HOLD) Higher Composite PATH
Trailing 12M Revenue (USD)
Operating Scale
$592M $1.72B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
44.1% 82.6% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 13.7x EV/Rev 0.41x PEG · 3.7x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$1.32B ($3.50B Net Debt) $363M ($528M Net Cash) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon PATH +3.11 pp
CORZ: -0.04% · PATH: +3.07%
3M Horizon PATH +13.52 pp
CORZ: -28.51% · PATH: -14.99%
6M Horizon PATH +67.31 pp
CORZ: -42.83% · PATH: +24.48%
1Y Horizon PATH +5.11 pp
CORZ: -11.11% · PATH: -6.0%

Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant USD Revenue & Operating Margin (%)
Period CORZ Revenue PATH Revenue CORZ Op. Margin PATH Op. Margin Margin Leader
FY2020 $60M $340M -10.5% -153.9% CORZ
FY2021 $540M $610M 24.2% -18.2% CORZ
FY2022 $640M $890M -329.5% -56.1% PATH
FY2023 $500M $1.06B 1.8% -32.9% CORZ
FY2024 $510M $1.31B -27.8% -12.6% PATH
FY2025 $320M $1.43B -77.0% -11.4% PATH
FY2026 N/A $1.61B N/A 3.5% PATH

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
CORZ BREAKDOWN
104d in phase · OBV ACCUMULATION
Current IV 80.6%
IV Percentile 28th %ile
Put/Call OI Skew 0.36x (Call-Skewed)
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow ACCUMULATION
Exact CORZ Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
PATH BREAKDOWN
54d in phase · OBV DISTRIBUTION
Current IV 50.3%
IV Percentile 11th %ile
Put/Call OI Skew 0.49x (Call-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow DISTRIBUTION
Exact PATH Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
CORZ Moat Profile Cyclical / Execution-Driven Positioning
Software - Infrastructure Operator
Competes within the Software - Infrastructure value chain with $4.6B market capitalization and -2.1% operating margin.
OpEx & R&D Reinvestment 46.2% of Rev ($274M)
90D Engineering Disclosures 0 Published
PATH Moat Profile Scale & Operating Efficiency Moat
Software - Infrastructure Operator
Competes within the Software - Infrastructure value chain with $6.8B market capitalization and 9.4% operating margin.
OpEx & R&D Reinvestment 73.2% of Rev ($1.26B)
90D Engineering Disclosures 0 Published

Investor FAQ CORZ vs PATH Key Questions & Quantitative Answers

As of Nov 16, 2026, UiPath, Inc. (PATH) is the stronger overall head-to-head candidate over Core Scientific, Inc. (CORZ) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Profitability & Quality, Balance Sheet & Cash Flow, R&D & Supply-Chain Moat). CORZ carries a Unified Composite Score of 40.2/100 (SELL) at $13.47 (16.6x Forward P/E, -2.1% operating margin), whereas PATH carries 58.3/100 (HOLD) at $13.24 (17.4x Forward P/E, 9.4% operating margin). Growth vs. Quality Trade-Off: PATH earns the overall head-to-head edge with a stronger Unified Composite Score (58.3/100 HOLD vs. CORZ 40.2/100 SELL) and 0.86β · 30% Vol risk profile, whereas CORZ leads top-line expansion (+187.1% YoY revenue growth, N/M PEG, and 3 of 6 institutional pillars) for higher-beta growth mandates. Technical & Structure Timing Caution: CORZ is currently in a Breakdown options structure phase (RSI 46.9); meanwhile PATH is in a Weinstein Distribution regime near a flattening 50-day moving average and Breakdown options structure phase (RSI 47.4). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

CORZ leads the Growth & Scale pillar: CORZ posts +187.1% YoY revenue growth and +61.2% YoY earnings growth on $592M TTM revenue (44.1% gross margin, -2.1% operating margin), compared with PATH at +13.4% YoY revenue growth and N/A YoY earnings growth on $1.72B TTM revenue (82.6% gross margin, 9.4% operating margin). Across the 7-period historical trajectory (FY2020 to FY2026), CORZ cumulative revenue shifted +433.3% while PATH shifted +373.5%. In operating R&D and SG&A reinvestment, CORZ deploys 46.2% of Rev ($274M) (0 90-day corporate R&D disclosures) versus 73.2% of Rev ($1.26B) (0 disclosures) for PATH.

CORZ screens cheaper on headline valuation multiples. CORZ trades at 16.6x Forward P/E, 16.6x Trailing P/E, N/M PEG, and 13.7x EV/Revenue (unreported FCF margin), whereas PATH trades at 17.4x Forward P/E, 19.6x Trailing P/E, 0.41x PEG, and 3.7x EV/Revenue (21.1% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against CORZ (0.0% ROE) versus PATH (20.0% ROE) capital efficiency.

In options market volatility and institutional positioning, CORZ carries 80.6% implied volatility (28th %ile, Balanced (25th–60th %ile)), a 0.36x (Call-Skewed) Put/Call open-interest ratio, ACCUMULATION on-balance volume, and sits in a BREAKDOWN options structure phase (2.91β · 109% Vol realized risk). By comparison, PATH carries 50.3% implied volatility (11th %ile, Compressed (<25th %ile)), a 0.49x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a BREAKDOWN options structure phase (0.86β · 30% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.